董事介绍
注:董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Adriana Karaboutis | 女 | Independent Director | 62 | 39.10万美元 | 未持股 | 2025-07-01 |
| Donal O'Connor | 男 | Independent Director | 74 | 40.00万美元 | 未持股 | 2025-07-01 |
| Orlando D. Ashford | 男 | Chairman of the Board | 56 | 0.41万美元 | 未持股 | 2025-07-01 |
| Julia M. Brown | 女 | Independent Director | 55 | 未披露 | 未持股 | 2025-07-01 |
| Kevin Egan | -- | Independent Director | 59 | 未披露 | 未持股 | 2025-07-01 |
| Patrick Lockwood Taylor | 男 | President, Chief Executive Officer and Director | 56 | 未披露 | 未持股 | 2025-07-01 |
| Jonas Samuelson | -- | Independent Director | 56 | 未披露 | 未持股 | 2025-07-01 |
| Albert A. Manzone | 男 | Independent Director | 61 | 未披露 | 未持股 | 2025-07-01 |
| Bradley A. Alford | 男 | Independent Director | 68 | 38.75万美元 | 未持股 | 2025-07-01 |
| Geoffrey M. Parker | 男 | Independent Director | 60 | 38.75万美元 | 未持股 | 2025-07-01 |
| Jeffrey B. Kindler | 男 | Independent Director | 69 | 40.00万美元 | 未持股 | 2025-07-01 |
高管介绍
注:高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Robert Willis | 男 | Executive Vice President and Chief Human Resources Officer | 56 | 未披露 | 未持股 | 2025-07-01 |
| Eduardo Bezerra | 男 | Executive Vice President and Chief Financial Officer | 50 | 未披露 | 未持股 | 2025-07-01 |
| Patrick Lockwood Taylor | 男 | President, Chief Executive Officer and Director | 56 | 未披露 | 未持股 | 2025-07-01 |
| Charles Atkinson | 男 | Executive Vice President, General Counsel & Secretary | -- | 未披露 | 未持股 | 2025-07-01 |
| David Ball | 男 | Executive Vice President and Chief Brand and Digital Officer | -- | 未披露 | 未持股 | 2025-07-01 |
| Roberto Khoury | 男 | EVP and Chief Commercial Officer | -- | 未披露 | 未持股 | 2025-07-01 |
| Abbie Lennox | 女 | Executive Vice President and Chief Science Officer | -- | 未披露 | 未持股 | 2025-07-01 |
| Matt Winterman | 男 | Executive Vice President, Product Supply, Operations Strategy and Transformation Officer | -- | 未披露 | 未持股 | 2025-07-01 |
董事简历
中英对照 |  中文 |  英文- Adriana Karaboutis
-
Adriana Karaboutis于2020年7月22日当选为董事会成员。自2017年8月以来,她一直担任国家电网的集团首席信息和数字官,负责整个集团数字战略、信息系统和服务、数字安全和风险以及整体安全的开发。在她的职业生涯中,Karaboutis领导了几个全球品牌的数字化转型,包括Biogen Inc .,Dell Inc .,通用汽车公司和福特汽车公司。从2014年9月到2017年3月,她担任Biogen Inc.的技术、业务解决方案和企业事务执行副总裁,在Biogen Inc.她介绍了领先的数字合作伙伴,以建立通过核心信息技术战略在药物发现、开发和交付过程中提供价值的能力。在加入Biogen之前,Karaboutis在Dell担任副总裁和全球首席信息官,在推动创新文化和持续业务流程改进方面发挥了重要作用。20多年来,Karaboutis一直致力于技术创新,以推动复杂制造和加工行业的业务转型。Karaboutis持有韦恩州立大学(Wayne State University)计算机科学学士学位。自2017年5月以来,Karaboutis女士一直担任Perrigo Company plc (NYSE,非处方医疗保健产品提供商)的董事会成员。2015年2月至2020年5月,她还担任Advance Auto Parts, Inc.(纽约证券交易所)的董事会成员,这是一家汽车售后市场零部件供应商;2016年2月至2017年12月,她担任Blue Cross Blue Shield of Massachusetts的董事会成员。
Adriana Karaboutis,2017 - 2023 Group Chief Information & Digital Officer, National Grid plc, a multi-national energy/utility company.2014 - 2017 Executive Vice-President, Biogen Inc, a global biotechnology company.2015 – 2017 Independent Director, Member of Audit and Innovation Committees, Blue Cross Blue Shield of Massachusetts, a not-for-profit health insurer.2010 – 2014 Vice-President and Global Chief Information Officer, Dell inc, a global services and technology company.1989 – 2010 Multiple international and cross-functional Technology, Manufacturing, and Supply Chain leadership positions at Ford Motor Company (15 years) and General Motors (6 years). - Adriana Karaboutis于2020年7月22日当选为董事会成员。自2017年8月以来,她一直担任国家电网的集团首席信息和数字官,负责整个集团数字战略、信息系统和服务、数字安全和风险以及整体安全的开发。在她的职业生涯中,Karaboutis领导了几个全球品牌的数字化转型,包括Biogen Inc .,Dell Inc .,通用汽车公司和福特汽车公司。从2014年9月到2017年3月,她担任Biogen Inc.的技术、业务解决方案和企业事务执行副总裁,在Biogen Inc.她介绍了领先的数字合作伙伴,以建立通过核心信息技术战略在药物发现、开发和交付过程中提供价值的能力。在加入Biogen之前,Karaboutis在Dell担任副总裁和全球首席信息官,在推动创新文化和持续业务流程改进方面发挥了重要作用。20多年来,Karaboutis一直致力于技术创新,以推动复杂制造和加工行业的业务转型。Karaboutis持有韦恩州立大学(Wayne State University)计算机科学学士学位。自2017年5月以来,Karaboutis女士一直担任Perrigo Company plc (NYSE,非处方医疗保健产品提供商)的董事会成员。2015年2月至2020年5月,她还担任Advance Auto Parts, Inc.(纽约证券交易所)的董事会成员,这是一家汽车售后市场零部件供应商;2016年2月至2017年12月,她担任Blue Cross Blue Shield of Massachusetts的董事会成员。
- Adriana Karaboutis,2017 - 2023 Group Chief Information & Digital Officer, National Grid plc, a multi-national energy/utility company.2014 - 2017 Executive Vice-President, Biogen Inc, a global biotechnology company.2015 – 2017 Independent Director, Member of Audit and Innovation Committees, Blue Cross Blue Shield of Massachusetts, a not-for-profit health insurer.2010 – 2014 Vice-President and Global Chief Information Officer, Dell inc, a global services and technology company.1989 – 2010 Multiple international and cross-functional Technology, Manufacturing, and Supply Chain leadership positions at Ford Motor Company (15 years) and General Motors (6 years).
- Donal O'Connor
-
Donal O'Connor自2015年10月21日曾担任董事。O'Connor先生是Galco Steel ltd 和 Huttonread的主席,并且是 Perrigo Company plc以及多家爱尔兰的私营公司的非执行董事。他是Elan Corporation, plc的的非执行董事和审计委员会、领导力、发展和薪酬委员会和交易委员会的成员,直到它在2013年12月被Perrigo收购。2008年12月至2012年5月,他是Readymix plc的一个非执行董事、审计委员会主席和高级独立董事。2008年12月至2010年6月,他被爱尔兰政府任命为Anglo Irish Bank的董事长。1995年至2013年2月,他是Icarom plc爱尔兰高等法院的管理员。2001年至2009年,O'Connor先生是爱尔兰审计委员会和会计监督管理局的成员,从成立起,担任一个临时董事会成员。2003年至2008年,他是PricewaterhouseCoopers(PwC)全球董事会的成员 PwC Eurofirms 董事会的前主席。O'Connor先生在1972年最初加入PwC,在1983年任命为合伙人。之后,他于1988年任命为合伙人,负责PwC的金融服务业务;1992年,担任审计实践的领导者。他于1994年被选为高级合伙人,1998年和2003年再次当选。2007年6月之前,他曾担任PwC Ireland的高级合伙人超过12年。O'Connor先生获得University College Dublin的商学士学位,并是爱尔兰特许会计师协会的会员。
Donal O'Connor has served as a director since October 21 2015. Mr. O'Connor is the Chairman of Galco Steel ltd and Huttonread, and is a non-executive Director of Perrigo Company plc and a number of Irish private companies. He was a non-executive Director and member of the audit committee, leadership, development and compensation committee and transactions committee of Elan Corporation, plc, until it was acquired by Perrigo in December 2013. He was a non-executive Director, chairman of the audit committee and senior independent director of Readymix plc from December 2008 until May 2012. He was appointed by the Irish Government as Chairman of Anglo Irish Bank from December 2008 until June 2010. He was the Irish High Court appointed Administrator of Icarom plc from 1995 until February 2013.Mr. O'Connor was a member of the Board of the Irish Auditing and Accountancy Supervisory Authority from its inception as an Interim Board in 2001 until 2009. He was a member of PricewaterhouseCoopers' "PwC" Global Board from 2003 until 2008 and is a former Chairman of the PwC Eurofirms Board. Mr. O'Connor originally joined PwC in 1972 and was appointed partner in 1983. He was later appointed partner in charge of the PwC Financial Services practice in 1988 and leader of the Audit Practice in 1992. He was elected Senior Partner in 1994 and was re-elected in 1998 and 2003. He served as Senior Partner of PwC Ireland for over twelve years until June 2007. Mr. O'Connor obtained a Bachelor of Commerce degree from University College Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland. - Donal O'Connor自2015年10月21日曾担任董事。O'Connor先生是Galco Steel ltd 和 Huttonread的主席,并且是 Perrigo Company plc以及多家爱尔兰的私营公司的非执行董事。他是Elan Corporation, plc的的非执行董事和审计委员会、领导力、发展和薪酬委员会和交易委员会的成员,直到它在2013年12月被Perrigo收购。2008年12月至2012年5月,他是Readymix plc的一个非执行董事、审计委员会主席和高级独立董事。2008年12月至2010年6月,他被爱尔兰政府任命为Anglo Irish Bank的董事长。1995年至2013年2月,他是Icarom plc爱尔兰高等法院的管理员。2001年至2009年,O'Connor先生是爱尔兰审计委员会和会计监督管理局的成员,从成立起,担任一个临时董事会成员。2003年至2008年,他是PricewaterhouseCoopers(PwC)全球董事会的成员 PwC Eurofirms 董事会的前主席。O'Connor先生在1972年最初加入PwC,在1983年任命为合伙人。之后,他于1988年任命为合伙人,负责PwC的金融服务业务;1992年,担任审计实践的领导者。他于1994年被选为高级合伙人,1998年和2003年再次当选。2007年6月之前,他曾担任PwC Ireland的高级合伙人超过12年。O'Connor先生获得University College Dublin的商学士学位,并是爱尔兰特许会计师协会的会员。
- Donal O'Connor has served as a director since October 21 2015. Mr. O'Connor is the Chairman of Galco Steel ltd and Huttonread, and is a non-executive Director of Perrigo Company plc and a number of Irish private companies. He was a non-executive Director and member of the audit committee, leadership, development and compensation committee and transactions committee of Elan Corporation, plc, until it was acquired by Perrigo in December 2013. He was a non-executive Director, chairman of the audit committee and senior independent director of Readymix plc from December 2008 until May 2012. He was appointed by the Irish Government as Chairman of Anglo Irish Bank from December 2008 until June 2010. He was the Irish High Court appointed Administrator of Icarom plc from 1995 until February 2013.Mr. O'Connor was a member of the Board of the Irish Auditing and Accountancy Supervisory Authority from its inception as an Interim Board in 2001 until 2009. He was a member of PricewaterhouseCoopers' "PwC" Global Board from 2003 until 2008 and is a former Chairman of the PwC Eurofirms Board. Mr. O'Connor originally joined PwC in 1972 and was appointed partner in 1983. He was later appointed partner in charge of the PwC Financial Services practice in 1988 and leader of the Audit Practice in 1992. He was elected Senior Partner in 1994 and was re-elected in 1998 and 2003. He served as Senior Partner of PwC Ireland for over twelve years until June 2007. Mr. O'Connor obtained a Bachelor of Commerce degree from University College Dublin and is a Fellow of the Institute of Chartered Accountants in Ireland.
- Orlando D. Ashford
-
Orlando D. Ashford自2020年12月起担任Perrigo Company Plc董事。Ashford先生是纽约Sycamore Partners的战略顾问,分别自2011年12月和2020年10月起担任ITT,Inc.和ArrayTechnologies,Inc.的董事会成员。他最近曾担任Holland America Line的总裁,领导屡获殊荣的Cruise Line的品牌和业务,此前曾担任全球咨询公司Mercer的人才业务部门总裁。任职Mercer公司之前,他曾担任Mercer公司的母公司Marsh & McLennan Companies的高级副总裁、首席人力资源和通信官,也曾担任Coca-Cola Company、Motorola公司的多种领导职务。Ashford先生拥有普渡大学的组织领导和工业技术理学学士学位和理学硕士学位。他也是执行董事领导委员会和ROADS Charter 高中的董事会成员。他还担任Purdue大学技术学院和NFL球员协会咨询委员会委员。
Orlando D. Ashford,February 2025 – Present: Interim CEO, National Black MBA Association.2022 - January 2025 Chief People Officer, Fanatics Holdings Inc, a global sporting company.2021 – 2022 Executive Chairman, Azamara Cruise Lines, a worldwide cruise line company.2014 - 2020 President, Holland America Line, a worldwide cruise line company.2020 - 2021 Strategic Advisor, Sycamore Partners, a private equity firm. - Orlando D. Ashford自2020年12月起担任Perrigo Company Plc董事。Ashford先生是纽约Sycamore Partners的战略顾问,分别自2011年12月和2020年10月起担任ITT,Inc.和ArrayTechnologies,Inc.的董事会成员。他最近曾担任Holland America Line的总裁,领导屡获殊荣的Cruise Line的品牌和业务,此前曾担任全球咨询公司Mercer的人才业务部门总裁。任职Mercer公司之前,他曾担任Mercer公司的母公司Marsh & McLennan Companies的高级副总裁、首席人力资源和通信官,也曾担任Coca-Cola Company、Motorola公司的多种领导职务。Ashford先生拥有普渡大学的组织领导和工业技术理学学士学位和理学硕士学位。他也是执行董事领导委员会和ROADS Charter 高中的董事会成员。他还担任Purdue大学技术学院和NFL球员协会咨询委员会委员。
- Orlando D. Ashford,February 2025 – Present: Interim CEO, National Black MBA Association.2022 - January 2025 Chief People Officer, Fanatics Holdings Inc, a global sporting company.2021 – 2022 Executive Chairman, Azamara Cruise Lines, a worldwide cruise line company.2014 - 2020 President, Holland America Line, a worldwide cruise line company.2020 - 2021 Strategic Advisor, Sycamore Partners, a private equity firm.
- Julia M. Brown
-
从2020年到2021年,Julia M. Brown担任Mars Wrigley的首席采购官,Mars Wrigley是Mars,Incorporated的一个部门,Mars,Incorporated是一家全球糖果、食品和宠物护理产品和服务制造商。2015年至2020年,她担任嘉年华邮轮公司 & plc NYSE:CCL的首席采购官。2008年至2015年,她在卡夫食品(纳斯达克股票代码:KHC)担任首席采购官,随后在2012年从卡夫食品公司分拆出来的亿滋国际公司(纳斯达克股票代码:MDLZ)担任首席采购官。Brown女士于2005年至2008年在高乐氏公司(纽约证券交易所代码:CLX)担任企业采购和合同制造副总裁。2004年至2005年,她在吉列公司担任采购、全球直接材料和战略采购高级总监。2001年至2003年,她在帝亚吉欧公司担任采购、收购整合和开发总监,1999年至2001年,她担任全球化妆品采购集团负责人。从1991年到1999年,她在宝洁公司(NYSE:PG)担任过各种职责不断增加的角色,包括从1995年到1999年的高级采购经理。自2020年起,她担任美国摄影、摄影产品和图像共享公司Shutterfly Inc.的董事。自2021年起,Solo Brands, Inc.(纽约证券交易所代码:DTC)是一个直接面向消费者的快速增长的生活方式品牌平台,自2022年起担任威尼斯人度假村和金沙博览会议中心的所有者Pioneer TopCO GP LLC.Brown女士拥有加拿大汉密尔顿麦克马斯特大学荣誉商学学士学位。
Julia M. Brown,2020 – 2021 Chief Procurement & Sustainability Officer, Mars Wrigley, a world leading manufacturer of chocolate and confectionery.2015 – 2020 Chief Procurement Officer, Carnival Corporation & plc, the world's largest global cruising company with 9 brands. - 从2020年到2021年,Julia M. Brown担任Mars Wrigley的首席采购官,Mars Wrigley是Mars,Incorporated的一个部门,Mars,Incorporated是一家全球糖果、食品和宠物护理产品和服务制造商。2015年至2020年,她担任嘉年华邮轮公司 & plc NYSE:CCL的首席采购官。2008年至2015年,她在卡夫食品(纳斯达克股票代码:KHC)担任首席采购官,随后在2012年从卡夫食品公司分拆出来的亿滋国际公司(纳斯达克股票代码:MDLZ)担任首席采购官。Brown女士于2005年至2008年在高乐氏公司(纽约证券交易所代码:CLX)担任企业采购和合同制造副总裁。2004年至2005年,她在吉列公司担任采购、全球直接材料和战略采购高级总监。2001年至2003年,她在帝亚吉欧公司担任采购、收购整合和开发总监,1999年至2001年,她担任全球化妆品采购集团负责人。从1991年到1999年,她在宝洁公司(NYSE:PG)担任过各种职责不断增加的角色,包括从1995年到1999年的高级采购经理。自2020年起,她担任美国摄影、摄影产品和图像共享公司Shutterfly Inc.的董事。自2021年起,Solo Brands, Inc.(纽约证券交易所代码:DTC)是一个直接面向消费者的快速增长的生活方式品牌平台,自2022年起担任威尼斯人度假村和金沙博览会议中心的所有者Pioneer TopCO GP LLC.Brown女士拥有加拿大汉密尔顿麦克马斯特大学荣誉商学学士学位。
- Julia M. Brown,2020 – 2021 Chief Procurement & Sustainability Officer, Mars Wrigley, a world leading manufacturer of chocolate and confectionery.2015 – 2020 Chief Procurement Officer, Carnival Corporation & plc, the world's largest global cruising company with 9 brands.
- Kevin Egan
-
Kevin Egan,1998 – 2024年,普华永道爱尔兰审计和鉴证合伙人。2007 – 2015年,普华永道爱尔兰审计和鉴证主管。2021 –现任爱尔兰国立大学审计委员会成员。
Kevin Egan,1998 – 2024 Partner, Audit and Assurance, PwC Ireland.2007 – 2015 Head of Audit and Assurance, PwC Ireland.2021 – Present a member of the Audit Committee of the National University of Ireland. - Kevin Egan,1998 – 2024年,普华永道爱尔兰审计和鉴证合伙人。2007 – 2015年,普华永道爱尔兰审计和鉴证主管。2021 –现任爱尔兰国立大学审计委员会成员。
- Kevin Egan,1998 – 2024 Partner, Audit and Assurance, PwC Ireland.2007 – 2015 Head of Audit and Assurance, PwC Ireland.2021 – Present a member of the Audit Committee of the National University of Ireland.
- Patrick Lockwood Taylor
-
Patrick Lockwood Taylor被任命为Perrigo Company PLC的总裁、首席执行官兼董事会成员,自2023年6月30日起生效。他从拜耳加入培瑞克,在那里他担任消费者健康北美区域总裁,同时还在拜耳之前担任拜耳美国公司总裁。在拜耳之前,洛克伍德-泰勒先生曾担任私营公司Oneida Group Inc.的总裁兼首席执行官。在担任此职位之前,他曾在宝洁工作了20多年,担任过多个职务,包括品牌特许经营和一般管理领导职务。
Patrick Lockwood Taylor,was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective June 30, 2023. He joined Perrigo from Bayer, where he was Regional President of Consumer Health North America, while also serving a dual role as President of Bayer U.S. Before Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions. - Patrick Lockwood Taylor被任命为Perrigo Company PLC的总裁、首席执行官兼董事会成员,自2023年6月30日起生效。他从拜耳加入培瑞克,在那里他担任消费者健康北美区域总裁,同时还在拜耳之前担任拜耳美国公司总裁。在拜耳之前,洛克伍德-泰勒先生曾担任私营公司Oneida Group Inc.的总裁兼首席执行官。在担任此职位之前,他曾在宝洁工作了20多年,担任过多个职务,包括品牌特许经营和一般管理领导职务。
- Patrick Lockwood Taylor,was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective June 30, 2023. He joined Perrigo from Bayer, where he was Regional President of Consumer Health North America, while also serving a dual role as President of Bayer U.S. Before Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions.
- Jonas Samuelson
-
Jonas Samuelson,2016 – 2025年1月,AB Electrolux总裁兼首席执行官。2011 – 2016年,Electrolux欧洲、中东和非洲主要电器首席执行官。2008 – 2011年,Electrolux Group首席财务官。2005 – 2008年,Munters AB.首席财务官兼执行副总裁。
Jonas Samuelson,2016 – January 2025, President & CEO, AB Electrolux.2011 – 2016, CEO, Major Appliances, Electrolux Europe, Middle East and Africa.2008 – 2011, CFO Electrolux Group.2005 – 2008, CFO and EVP, Munters AB. - Jonas Samuelson,2016 – 2025年1月,AB Electrolux总裁兼首席执行官。2011 – 2016年,Electrolux欧洲、中东和非洲主要电器首席执行官。2008 – 2011年,Electrolux Group首席财务官。2005 – 2008年,Munters AB.首席财务官兼执行副总裁。
- Jonas Samuelson,2016 – January 2025, President & CEO, AB Electrolux.2011 – 2016, CEO, Major Appliances, Electrolux Europe, Middle East and Africa.2008 – 2011, CFO Electrolux Group.2005 – 2008, CFO and EVP, Munters AB.
- Albert A. Manzone
-
Albert A. Manzone于1993年至1997年任职于麦肯锡公司,随后在百事可乐(NASDAQ:PEP)工作了十多年,参与了全球运营中的许多关键举措,包括对Tropicana、Quaker和Tropicana的收购和关闭后运营整合。Manzone先生曾担任多个行政领导职务,包括百事公司Shelf Stable Juices北美区总裁、Oettinger Davidoff AG欧洲区总裁;诺华公司(NYSE:NVS)东南欧消费者健康总裁;WM. Wrigley Jr.公司欧洲区总裁;以及Whole Earth Brands(NASDAQ:FREE)的首席执行官,该公司成功实现了扭亏为盈,公司规模翻了一番,并通过在纳斯达克上市成功地将其上市。Manzone先生担任培瑞克(NYSE:PRGO)董事会审计委员会董事和成员;Northstern校友会董事会前任主席;摩纳哥环境基金会Price Albert II董事。他拥有Northstern大学家乐氏管理研究生院BINCE Administration硕士学位,以及索邦大学国际BINCE研究生学位。
Albert A. Manzone was at McKinsey and Company from 1993 1997, follod by PepsiCo (NASDAQ: PEP) for over a decade, working on many critical initiatives in the global operations including the acquisition and postclose operations integration of Tropicana, Quaker, and Tropicana. Mr. Manzone has held numero executive leadership roles including President PepsiCo Shelf Stable Juices North America, President, Europe at Oettinger Davidoff AG; President Consumer Health, Southeast Europe, at Novartis (NYSE: NVS); President, Europe at Wm. Wrigley Jr. Company; and CEO of Whole Earth Brands (NASDAQ: FREE) leading a successful turnaround, doubling the company size and succesfully taking it public through a NASDAQ listing. Mr. Manzone serves as Director and Member of the Audit Committee on the Perrigo (NYSE: PRGO) Board; Past President of the Board of the Northstern Alumni Association; and Director of the Price Albert II of Monaco Foundation for the Environment. He holds a Master of Biness Administration from the Kellogg Graduate School of Management at Northstern University, and a graduate degree in international biness from the Sorbonne University. - Albert A. Manzone于1993年至1997年任职于麦肯锡公司,随后在百事可乐(NASDAQ:PEP)工作了十多年,参与了全球运营中的许多关键举措,包括对Tropicana、Quaker和Tropicana的收购和关闭后运营整合。Manzone先生曾担任多个行政领导职务,包括百事公司Shelf Stable Juices北美区总裁、Oettinger Davidoff AG欧洲区总裁;诺华公司(NYSE:NVS)东南欧消费者健康总裁;WM. Wrigley Jr.公司欧洲区总裁;以及Whole Earth Brands(NASDAQ:FREE)的首席执行官,该公司成功实现了扭亏为盈,公司规模翻了一番,并通过在纳斯达克上市成功地将其上市。Manzone先生担任培瑞克(NYSE:PRGO)董事会审计委员会董事和成员;Northstern校友会董事会前任主席;摩纳哥环境基金会Price Albert II董事。他拥有Northstern大学家乐氏管理研究生院BINCE Administration硕士学位,以及索邦大学国际BINCE研究生学位。
- Albert A. Manzone was at McKinsey and Company from 1993 1997, follod by PepsiCo (NASDAQ: PEP) for over a decade, working on many critical initiatives in the global operations including the acquisition and postclose operations integration of Tropicana, Quaker, and Tropicana. Mr. Manzone has held numero executive leadership roles including President PepsiCo Shelf Stable Juices North America, President, Europe at Oettinger Davidoff AG; President Consumer Health, Southeast Europe, at Novartis (NYSE: NVS); President, Europe at Wm. Wrigley Jr. Company; and CEO of Whole Earth Brands (NASDAQ: FREE) leading a successful turnaround, doubling the company size and succesfully taking it public through a NASDAQ listing. Mr. Manzone serves as Director and Member of the Audit Committee on the Perrigo (NYSE: PRGO) Board; Past President of the Board of the Northstern Alumni Association; and Director of the Price Albert II of Monaco Foundation for the Environment. He holds a Master of Biness Administration from the Kellogg Graduate School of Management at Northstern University, and a graduate degree in international biness from the Sorbonne University.
- Bradley A. Alford
-
Bradley A. Alford,2006年1月到2012年10月他担任雀巢美国(一家营养、保健和健康公司)的董事长和首席执行官;2003年到2005年12月担任雀巢的品牌公司雀巢美国的总裁兼首席执行官。
Bradley A. Alford,2016 - 2021 Operating Partner, Advent International Corporation, a global private equity firm.2014 - 2016 Industry Advisor, Advent International Corporation.2006 - 2013 Chairman / CEO, Nestlé USA, a multinational food and beverage company. - Bradley A. Alford,2006年1月到2012年10月他担任雀巢美国(一家营养、保健和健康公司)的董事长和首席执行官;2003年到2005年12月担任雀巢的品牌公司雀巢美国的总裁兼首席执行官。
- Bradley A. Alford,2016 - 2021 Operating Partner, Advent International Corporation, a global private equity firm.2014 - 2016 Industry Advisor, Advent International Corporation.2006 - 2013 Chairman / CEO, Nestlé USA, a multinational food and beverage company.
- Geoffrey M. Parker
-
Geoffrey M. Parker自2016年11月起担任Perrigo的董事。自2017年4月以来,Parker先生一直担任生物制药公司Tricida, Inc.的首席财务官。Parker先生曾于2010年9月至2015年5月担任生物制药公司Anacor制药的首席财务官。从1997年到2009年,Parker先生在高盛领导西海岸医疗保健投资银行业务,在那里他为生物技术、生命科学工具和医疗器械行业的领先公司提供咨询。Parker先生自2009年12月起担任ChemoCentryx董事会成员。Parker先生曾于2016年6月至2019年11月担任基因组健康董事会成员,并于2016年3月至2017年12月担任Sunesis Pharmaceuticals董事会成员。
Geoffrey M. Parker,2023 - Present Executive Vice Present & Chief Financial Officer, Allogene Therapeutics, Inc, a biotechnology company.2017 - 2023 Chief Operating Officer & Chief Financial Officer, Tricida, Inc, a biotechnology company.2010 - 2015 Chief Financial Officer, Anacor Pharmaceuticals, Inc., a biotechnology company.1997 - 2009 Managing Director and Partner, Healthcare Investment Banking, Goldman Sachs, a multinational investment bank and financial service company. - Geoffrey M. Parker自2016年11月起担任Perrigo的董事。自2017年4月以来,Parker先生一直担任生物制药公司Tricida, Inc.的首席财务官。Parker先生曾于2010年9月至2015年5月担任生物制药公司Anacor制药的首席财务官。从1997年到2009年,Parker先生在高盛领导西海岸医疗保健投资银行业务,在那里他为生物技术、生命科学工具和医疗器械行业的领先公司提供咨询。Parker先生自2009年12月起担任ChemoCentryx董事会成员。Parker先生曾于2016年6月至2019年11月担任基因组健康董事会成员,并于2016年3月至2017年12月担任Sunesis Pharmaceuticals董事会成员。
- Geoffrey M. Parker,2023 - Present Executive Vice Present & Chief Financial Officer, Allogene Therapeutics, Inc, a biotechnology company.2017 - 2023 Chief Operating Officer & Chief Financial Officer, Tricida, Inc, a biotechnology company.2010 - 2015 Chief Financial Officer, Anacor Pharmaceuticals, Inc., a biotechnology company.1997 - 2009 Managing Director and Partner, Healthcare Investment Banking, Goldman Sachs, a multinational investment bank and financial service company.
- Jeffrey B. Kindler
-
Jeffrey B. Kindler,一些私人保健服务公司董事、顾问及投资者。他现任一家私营制药公司Centrexion公司的首席执行官。除了Chipotle,他还在两家其他上市公司的董事会及几个非营利组织工作过;两家上市公司是Intrexon公司(纽约证券交易所:XON)和Siga科技公司(纳克达斯全球交易市场:SIGA)。他于2010年12月从辉瑞制药公司退休,曾于此担任董事长兼首席执行官。他于2002年进入辉瑞担任高级副总裁兼总顾问,且被指派的职务职责不断提高,直到2006年被任命为首席执行官。在进入辉瑞之前,他是麦当劳公司的行政人员;且在2001年期间,他接手负责该公司的合伙品牌集团(Chipotle也包含在内)。
Jeffrey B. Kindler,2020 - Present Venture Partner, Artis Ventures, venture fund focused on life-sciences companies.2020 - Present Senior Advisor, Blackstone Group, the world's largest alternative asset manager.2013 - Present CEO, Centrexion Corporation, a biopharmaceutical company. - Jeffrey B. Kindler,一些私人保健服务公司董事、顾问及投资者。他现任一家私营制药公司Centrexion公司的首席执行官。除了Chipotle,他还在两家其他上市公司的董事会及几个非营利组织工作过;两家上市公司是Intrexon公司(纽约证券交易所:XON)和Siga科技公司(纳克达斯全球交易市场:SIGA)。他于2010年12月从辉瑞制药公司退休,曾于此担任董事长兼首席执行官。他于2002年进入辉瑞担任高级副总裁兼总顾问,且被指派的职务职责不断提高,直到2006年被任命为首席执行官。在进入辉瑞之前,他是麦当劳公司的行政人员;且在2001年期间,他接手负责该公司的合伙品牌集团(Chipotle也包含在内)。
- Jeffrey B. Kindler,2020 - Present Venture Partner, Artis Ventures, venture fund focused on life-sciences companies.2020 - Present Senior Advisor, Blackstone Group, the world's largest alternative asset manager.2013 - Present CEO, Centrexion Corporation, a biopharmaceutical company.
高管简历
中英对照 |  中文 |  英文- Robert Willis
Robert Willis担任人力资源全球业务副总裁近六年后,于2019年3月被任命为执行副总裁兼首席人力资源官。加入Perrigo之前,Willis先生在中东的Fawaz Alhokair集团,英国和爱尔兰的GE Capital,北美和国际上的DoubleClick以及欧洲的Norkom Technologies担任过人力资源领导者,积累了20多年的经验。他还是黑白集团的合伙人和创始成员。
Robert Willis,was named Executive Vice President and Chief Human Resources Officer in March 2019 after serving as Vice President of Human Resources Global Businesses for nearly six years. Prior to joining Perrigo, Mr. Willis gained more than 20 years of experience in Human Resources leadership through roles with Fawaz Alhokair Group, GE Capital, DoubleClick, and Norkom Technologies.- Robert Willis担任人力资源全球业务副总裁近六年后,于2019年3月被任命为执行副总裁兼首席人力资源官。加入Perrigo之前,Willis先生在中东的Fawaz Alhokair集团,英国和爱尔兰的GE Capital,北美和国际上的DoubleClick以及欧洲的Norkom Technologies担任过人力资源领导者,积累了20多年的经验。他还是黑白集团的合伙人和创始成员。
- Robert Willis,was named Executive Vice President and Chief Human Resources Officer in March 2019 after serving as Vice President of Human Resources Global Businesses for nearly six years. Prior to joining Perrigo, Mr. Willis gained more than 20 years of experience in Human Resources leadership through roles with Fawaz Alhokair Group, GE Capital, DoubleClick, and Norkom Technologies.
- Eduardo Bezerra
Eduardo Bezerra自2019年3月起担任高级副总裁兼首席财务官。在此之前,他于2017年1月至2019年2月担任全球领先的农产品供应商孟山都公司的全球金融整合主管,负责与孟山都公司收购相关的金融整合等事务。此外,Bezerra先生曾于2014年9月至2016年12月在孟山都公司担任国际业务首席财务官兼全球金融共享服务主管,并于2009年至2014年8月担任巴西首席财务官。Bezerra先生在孟山都公司任职超过20年期间,还在国际上担任过多个金融,商业和战略职务,包括在巴西,阿根廷,中美洲和美国。
Eduardo Bezerra has served as Senior Vice President and Chief Financial Officer since March 2019. Prior to that time, he served as the Global Finance Integration Lead at Monsanto Company, a leading global provider of agricultural products, from January 2017 until February 2019 where he was responsible for, among other things, the financial integration associated with Monsanto Company’s acquisition by Bayer AG. In addition, Mr. Bezerra previously served at Monsanto Company as International Business Chief Financial Officer and Head of Global Finance Shared Services from September 2014 until December 2016 and as Brazil Chief Financial Officer from 2009 until August 2014. Mr. Bezerra also served in multiple financial, commercial and strategic roles internationally during his tenure of over 20 years with Monsanto Company, including in Brazil, Argentina, Central America and the United States.- Eduardo Bezerra自2019年3月起担任高级副总裁兼首席财务官。在此之前,他于2017年1月至2019年2月担任全球领先的农产品供应商孟山都公司的全球金融整合主管,负责与孟山都公司收购相关的金融整合等事务。此外,Bezerra先生曾于2014年9月至2016年12月在孟山都公司担任国际业务首席财务官兼全球金融共享服务主管,并于2009年至2014年8月担任巴西首席财务官。Bezerra先生在孟山都公司任职超过20年期间,还在国际上担任过多个金融,商业和战略职务,包括在巴西,阿根廷,中美洲和美国。
- Eduardo Bezerra has served as Senior Vice President and Chief Financial Officer since March 2019. Prior to that time, he served as the Global Finance Integration Lead at Monsanto Company, a leading global provider of agricultural products, from January 2017 until February 2019 where he was responsible for, among other things, the financial integration associated with Monsanto Company’s acquisition by Bayer AG. In addition, Mr. Bezerra previously served at Monsanto Company as International Business Chief Financial Officer and Head of Global Finance Shared Services from September 2014 until December 2016 and as Brazil Chief Financial Officer from 2009 until August 2014. Mr. Bezerra also served in multiple financial, commercial and strategic roles internationally during his tenure of over 20 years with Monsanto Company, including in Brazil, Argentina, Central America and the United States.
- Patrick Lockwood Taylor
Patrick Lockwood Taylor被任命为Perrigo Company PLC的总裁、首席执行官兼董事会成员,自2023年6月30日起生效。他从拜耳加入培瑞克,在那里他担任消费者健康北美区域总裁,同时还在拜耳之前担任拜耳美国公司总裁。在拜耳之前,洛克伍德-泰勒先生曾担任私营公司Oneida Group Inc.的总裁兼首席执行官。在担任此职位之前,他曾在宝洁工作了20多年,担任过多个职务,包括品牌特许经营和一般管理领导职务。
Patrick Lockwood Taylor,was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective June 30, 2023. He joined Perrigo from Bayer, where he was Regional President of Consumer Health North America, while also serving a dual role as President of Bayer U.S. Before Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions.- Patrick Lockwood Taylor被任命为Perrigo Company PLC的总裁、首席执行官兼董事会成员,自2023年6月30日起生效。他从拜耳加入培瑞克,在那里他担任消费者健康北美区域总裁,同时还在拜耳之前担任拜耳美国公司总裁。在拜耳之前,洛克伍德-泰勒先生曾担任私营公司Oneida Group Inc.的总裁兼首席执行官。在担任此职位之前,他曾在宝洁工作了20多年,担任过多个职务,包括品牌特许经营和一般管理领导职务。
- Patrick Lockwood Taylor,was appointed President, Chief Executive Officer and Board Member of Perrigo Company plc, effective June 30, 2023. He joined Perrigo from Bayer, where he was Regional President of Consumer Health North America, while also serving a dual role as President of Bayer U.S. Before Bayer, Mr. Lockwood-Taylor served as President and CEO of The Oneida Group Inc., a private company. Prior to this position, he spent more than 20 years with Procter & Gamble in various roles, including brand franchise and general management leadership positions.
- Charles Atkinson
查尔斯·阿特金森,于2024年10月被任命为执行副总裁、总法律顾问兼秘书。Atkinson先生加入培瑞克之前任职于Haleon PLC及其前身GSK PLC,最近担任首席法律和合规官及临时总法律顾问。在Haleon/GSK合计任职的20多年里,阿特金森先生成功地为众多交易和整合提供了咨询服务,包括创建Haleon以及随后与其母股东GSK和辉瑞的分离。他还曾担任公司法律的全球主管,并担任自理业务各个部分的首席法律顾问,包括供应链、研发和创新、业务发展和知识产权。
Charles Atkinson,was named Executive Vice President, General Counsel & Secretary, in October 2024. Mr. Atkinson joins Perrigo from Haleon plc and its predecessor, GSK plc, most recently serving as chief legal and compliance officer and Interim General Counsel. During his 20-plus year combined tenure at Haleon/GSK, Mr. Atkinson successfully advised across numerous transactions and integrations, including the creation of Haleon and subsequent separation from its parent shareholders GSK and Pfizer. He has also served as global head of corporate legal and was lead counsel for various parts of the self-care business, including supply chain, R&D and innovation, business development, and intellectual property.- 查尔斯·阿特金森,于2024年10月被任命为执行副总裁、总法律顾问兼秘书。Atkinson先生加入培瑞克之前任职于Haleon PLC及其前身GSK PLC,最近担任首席法律和合规官及临时总法律顾问。在Haleon/GSK合计任职的20多年里,阿特金森先生成功地为众多交易和整合提供了咨询服务,包括创建Haleon以及随后与其母股东GSK和辉瑞的分离。他还曾担任公司法律的全球主管,并担任自理业务各个部分的首席法律顾问,包括供应链、研发和创新、业务发展和知识产权。
- Charles Atkinson,was named Executive Vice President, General Counsel & Secretary, in October 2024. Mr. Atkinson joins Perrigo from Haleon plc and its predecessor, GSK plc, most recently serving as chief legal and compliance officer and Interim General Counsel. During his 20-plus year combined tenure at Haleon/GSK, Mr. Atkinson successfully advised across numerous transactions and integrations, including the creation of Haleon and subsequent separation from its parent shareholders GSK and Pfizer. He has also served as global head of corporate legal and was lead counsel for various parts of the self-care business, including supply chain, R&D and innovation, business development, and intellectual property.
- David Ball
David Ball,2024年8月被任命为执行副总裁兼首席品牌和数字官。在加入培瑞克之前,Dr. Ball最近于2019年至2024年在Bayer Consumer Healthcare and Care/of(在2020年被Bayer收购之前)任职,担任过多个职位,包括北美消化健康业务的总经理和营销副总裁。在此之前,鲍尔博士在宝洁公司工作了八年多,在多个业务部门和职能部门担任领导职务。
David Ball,was named Executive Vice President and Chief Brand and Digital Officer in August 2024. Prior to joining Perrigo, Dr. Ball was most recently at Bayer Consumer Healthcare and Care/of (prior to its acquisition by Bayer in 2020) from 2019 to 2024, where he held various positions including General Manager and Vice President of Marketing for the Digestive Health business in North America. Prior to this, Dr. Ball spent more than eight years at Procter and Gamble in leadership positions across multiple business units and functions.- David Ball,2024年8月被任命为执行副总裁兼首席品牌和数字官。在加入培瑞克之前,Dr. Ball最近于2019年至2024年在Bayer Consumer Healthcare and Care/of(在2020年被Bayer收购之前)任职,担任过多个职位,包括北美消化健康业务的总经理和营销副总裁。在此之前,鲍尔博士在宝洁公司工作了八年多,在多个业务部门和职能部门担任领导职务。
- David Ball,was named Executive Vice President and Chief Brand and Digital Officer in August 2024. Prior to joining Perrigo, Dr. Ball was most recently at Bayer Consumer Healthcare and Care/of (prior to its acquisition by Bayer in 2020) from 2019 to 2024, where he held various positions including General Manager and Vice President of Marketing for the Digestive Health business in North America. Prior to this, Dr. Ball spent more than eight years at Procter and Gamble in leadership positions across multiple business units and functions.
- Roberto Khoury
Roberto Khoury,于2024年5月被任命为执行副总裁兼Consumer Self Care International总裁。他在Kenvue(以前是强生的一部分)工作了六年多之后加入培瑞克,在那里他担任高级副总裁兼护肤组合总经理,包括品牌领导职责。在担任该职务之前,他领导了Kenvue在欧洲的消费品牌。在加入Kenvue之前,Khoury先生在欧莱雅工作了13年,在那里他担任过消费者领域的多个领导职务,其中包括在不断增长的领先品牌的泛欧线延伸方面任职。
Roberto Khoury,was named Executive Vice President and President, Consumer Self Care International in May 2024. He joined Perrigo after more than six years with Kenvue (formerly a part of Johnson & Johnson), where he was Senior Vice President and General Manager of their skin care portfolio, including brand leadership responsibilities. Prior to that role he led Kenvue's consumer brands in Europe. Before his time at Kenvue, Mr. Khoury spent 13 years at L'Oréal, where he held several leadership roles in the consumer space that included stints in growing pan-European line extensions of leading brands.- Roberto Khoury,于2024年5月被任命为执行副总裁兼Consumer Self Care International总裁。他在Kenvue(以前是强生的一部分)工作了六年多之后加入培瑞克,在那里他担任高级副总裁兼护肤组合总经理,包括品牌领导职责。在担任该职务之前,他领导了Kenvue在欧洲的消费品牌。在加入Kenvue之前,Khoury先生在欧莱雅工作了13年,在那里他担任过消费者领域的多个领导职务,其中包括在不断增长的领先品牌的泛欧线延伸方面任职。
- Roberto Khoury,was named Executive Vice President and President, Consumer Self Care International in May 2024. He joined Perrigo after more than six years with Kenvue (formerly a part of Johnson & Johnson), where he was Senior Vice President and General Manager of their skin care portfolio, including brand leadership responsibilities. Prior to that role he led Kenvue's consumer brands in Europe. Before his time at Kenvue, Mr. Khoury spent 13 years at L'Oréal, where he held several leadership roles in the consumer space that included stints in growing pan-European line extensions of leading brands.
- Abbie Lennox
Abbie 雷诺士,于2025年1月被任命为执行副总裁兼首席科学官。雷诺士女士从拜耳加盟培瑞克,于2019年至2024年期间担任执行委员会成员及首席信任和科学官,负责领导监管、医疗事务、安全和质量团队。在加入拜耳之前,她曾在Reckitt Benckiser担任监管事务领导职务,在那里她推进了该公司对跨多个健康和保健品牌的管道交付的监管方法。
Abbie Lennox,was named Executive Vice President and Chief Science Officer in January 2025. Ms. Lennox joins Perrigo from Bayer where she served as Executive Committee Member and Chief Trust and Science Officer from 2019 to 2024, responsible for leading the regulatory, medical affairs, safety and quality teams. Prior to her time at Bayer, she served in regulatory affairs leadership roles with Reckitt Benckiser, where she advanced the company's regulatory approach to pipeline delivery across multiple health and wellness brands.- Abbie 雷诺士,于2025年1月被任命为执行副总裁兼首席科学官。雷诺士女士从拜耳加盟培瑞克,于2019年至2024年期间担任执行委员会成员及首席信任和科学官,负责领导监管、医疗事务、安全和质量团队。在加入拜耳之前,她曾在Reckitt Benckiser担任监管事务领导职务,在那里她推进了该公司对跨多个健康和保健品牌的管道交付的监管方法。
- Abbie Lennox,was named Executive Vice President and Chief Science Officer in January 2025. Ms. Lennox joins Perrigo from Bayer where she served as Executive Committee Member and Chief Trust and Science Officer from 2019 to 2024, responsible for leading the regulatory, medical affairs, safety and quality teams. Prior to her time at Bayer, she served in regulatory affairs leadership roles with Reckitt Benckiser, where she advanced the company's regulatory approach to pipeline delivery across multiple health and wellness brands.
- Matt Winterman
Matt Winterman,曾担任阿斯利康全球供应链和战略高级副总裁,负责监管540亿美元的供应链,涵盖5000个SKU。在担任这一职务期间,他在推动制造业网络转型和战略投资方面发挥了重要作用。他还曾在罗氏集团(Roche Holding AG)担任端到端供应链的全球主管,并在GSK plc担任越来越多的技术运营战略和供应链绩效方面的职责。Winterman先生毕业于布里斯托大学,获得经济学理学学士学位。
Matt Winterman,served as SVP of Global Supply Chain and Strategy at AstraZeneca, overseeing a $54 billion supply chain across 5,000 SKUs. In this capacity, he was instrumental in driving transformation and strategic investment in the manufacturing network. He also served as Global Head of end-to-end Supply Chain at Roche Holding AG, and in roles of increasing responsibility for technical operations strategy and supply chain performance at GSK plc. Mr. Winterman graduated with a Bachelor of Science degree in Economics from the University of Bristol.- Matt Winterman,曾担任阿斯利康全球供应链和战略高级副总裁,负责监管540亿美元的供应链,涵盖5000个SKU。在担任这一职务期间,他在推动制造业网络转型和战略投资方面发挥了重要作用。他还曾在罗氏集团(Roche Holding AG)担任端到端供应链的全球主管,并在GSK plc担任越来越多的技术运营战略和供应链绩效方面的职责。Winterman先生毕业于布里斯托大学,获得经济学理学学士学位。
- Matt Winterman,served as SVP of Global Supply Chain and Strategy at AstraZeneca, overseeing a $54 billion supply chain across 5,000 SKUs. In this capacity, he was instrumental in driving transformation and strategic investment in the manufacturing network. He also served as Global Head of end-to-end Supply Chain at Roche Holding AG, and in roles of increasing responsibility for technical operations strategy and supply chain performance at GSK plc. Mr. Winterman graduated with a Bachelor of Science degree in Economics from the University of Bristol.